Product
Help
Pricing
About
Jobs
Log in
Get started
Award
Add to collection
107592
Funder:
Deutsche Krebshilfe
Funded outputs count:
19
Funder award ID:
107592
OpenAlex ID:
G7271482638
A machine learning–derived sarcopenia index is associated with survival and nonrelapse mortality in DLBCL
2026
·
Fabian Ullrich
, René Hosch
, et al.
·
Blood Advances
Risk prediction in diffuse large B-cell lymphoma improves when combining baseline PET features with interim PET response
2025
·
Jakoba J. Eertink
, Martijn W. Heymans
, et al.
·
Haematologica
·
2
PDF
Health-related quality of life in patients with aggressive non-Hodgkin lymphoma: results from the PETAL trial
2025
·
Ulrich Dührsen
, Gabriele Prange-Krex
, et al.
·
Annals of Hematology
PDF
Response-guided first-line therapy and treatment of relapse in aggressive lymphoma: 10-year follow-up of the PETAL trial
2024
·
Ulrich Dührsen
, Andreas Bockisch
, et al.
·
Blood Neoplasia
·
5
Baseline PET radiomics outperform the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma
2023
·
Jakoba Johanna Eertink
, Gerben JC Zwezerijnen
, et al.
·
Blood
·
38
PDF
Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma
2022
·
Jakoba J. Eertink
, Gerben J. C. Zwezerijnen
, et al.
·
Blood Advances
·
20
PDF
Interim FDG-PET analysis to identify patients with aggressive non-Hodgkin lymphoma who benefit from treatment intensification: a post-hoc analysis of the PETAL trial
2022
·
Robert Seifert
, David Kersting
, et al.
·
Leukemia
·
7
PDF
Cost-Effectiveness of Shortening Treatment Duration Based on Interim PET Outcome in Patients With Diffuse Large B-cell Lymphoma
2021
·
MJE Greuter
, JJ Eertink
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
3
PDF
Impact of germline polymorphisms in genes regulating glucose uptake on positron emission tomography findings and outcome in diffuse large B-cell lymphoma: results from the PETAL trial
2021
·
Martina Broecker-Preuss
, Nina Becher-Boveleth
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
5
PDF
FDG PET/CT to detect bone marrow involvement in the initial staging of patients with aggressive non-Hodgkin lymphoma: results from the prospective, multicenter PETAL and OPTIMAL>60 trials
2021
·
Dominic Kaddu-Mulindwa
, Bettina Altmann
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
40
PDF
FDG PET/CT to Detect Bone Marrow Involvement in the Initial Staging of Patients With Aggressive Non-Hodgkin Lymphoma: Results From the Prospective, Multicenter PETAL and OPTIMAL>60 Trials
2021
·
Dominic Kaddu-Mulindwa
, Bettina Altmann
, et al.
·
Research Square
PDF
Genetic Variants of the NKG2C/HLA-E Receptor–Ligand Axis Are Determinants of Progression-Free Survival and Therapy Outcome in Aggressive B-Cell Lymphoma
2020
·
Bettina Wagner
, Ulrich Dührsen
, et al.
·
Cancers
·
10
PDF
Impact of complete surgical resection on outcome in aggressive non‐Hodgkin lymphoma treated with immunochemotherapy
2020
·
Christine Schmitz
, Jan Rekowski
, et al.
·
Cancer Medicine
·
12
PDF
Baseline and interim PET‐based outcome prediction in peripheral T‐cell lymphoma: A subgroup analysis of the PETAL trial
2020
·
Christine Schmitz
, Jan Rekowski
, et al.
·
Hematological Oncology
·
27
PDF
Supporting data for positron emission tomography-based risk modelling using a fixed-instead of a relative thresholding method for total metabolic tumor volume determination
2019
·
Christine Schmitz
, Andreas Hüttmann
, et al.
·
Data in Brief
·
3
PDF
Dynamic risk assessment based on positron emission tomography scanning in diffuse large B-cell lymphoma: Post-hoc analysis from the PETAL trial
2019
·
Christine Schmitz
, Andreas Hüttmann
, et al.
·
European Journal of Cancer
·
99
Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome
2019
·
Julia Richter
, Andreas Hüttmann
, et al.
·
Blood Cancer Journal
·
17
PDF
Pitfalls of Interim Positron Emission Tomography Scanning in Diffuse Large B-Cell Lymphoma
2010
·
Andreas Hüttmann
, Stefan Müller
, et al.
·
Journal of Clinical Oncology
·
9
PDF
Show more works
View as search
Year
Topic